|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 95, 1003-1007, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
EM Gilbert, SK Krueger, JL Murray, DG Renlund, JB O'Connell, WA Gay and MR Bristow
Since the initiation of the UTAH Cardiac Transplant Program,
echocardiography has been used to evaluate 74 potential donors including 65
of 71 hearts ultimately used for transplantation. Of these 65 donors, 46
had normal studies, nine had pericardial effusions, five had mild septal
hypokinesia with otherwise normal function, four had equivocal mitral valve
prolapse, and only one heart could not be visualized. All transplants were
successful and all donor hearts exhibited satisfactory hemodynamic function
immediately after transplantation, including the hearts that were mildly
abnormal before transplantation. These hearts included 21 (29%) that could
have been excluded by conventional screening criteria. Nine potential donor
hearts with grossly abnormal echocardiograms were not used for
transplantation, including eight hearts with severe hypokinesia and one
heart with significant mitral and tricuspid regurgitation. Inspection or
histologic analysis confirmed the presence of severe dysfunction or
morphologic damage in those hearts subjected to these additional measures.
We conclude that echocardiographic screening is a useful method of
evaluating potential cardiac transplant donors. It can identify potential
donors that would otherwise have been excluded and it can identify
potential donors with severe cardiac dysfunction without the need for
direct surgical inspection.
ARTICLES
Echocardiographic evaluation of potential cardiac transplant donors
UTAH Cardiac Transplant Program, Salt Lake City.
This article has been cited by other articles:
![]() |
R.V. Venkateswaran, R.S. Bonser, and R.P. Steeds The echocardiographic assessment of donor heart function prior to cardiac transplantation Eur J Echocardiogr, August 1, 2005; 6(4): 260 - 263. [Full Text] [PDF] |
||||
![]() |
S. R. R. Hall, L. Wang, B. Milne, and M. Hong Central dexmedetomidine attenuates cardiac dysfunction in a rodent model of intracranial hypertension: [La dexmedetomidine centrale attenue la dysfonction cardiaque chez un modele rongeur d'hypertension intracranienne] Can J Anesth, December 1, 2004; 51(10): 1025 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Arab, A. M. Yahia, and A. I. Qureshi Cardiovascular Manifestations of Acute Intracranial Lesions: Pathophysiology, Manifestations, and Treatment J Intensive Care Med, May 1, 2003; 18(3): 119 - 129. [Abstract] [PDF] |
||||
![]() |
M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography Circulation, March 18, 1997; 95(6): 1686 - 1744. [Full Text] |
||||
![]() |
M. White, R. J. Wiechmann, R. L. Roden, M. B. Hagan, M. M. Wollmering, J. D. Port, E. Hammond, W. T. Abraham, E. E. Wolfel, J. Lindenfeld, et al. Cardiac ß-Adrenergic Neuroeffector Systems in Acute Myocardial Dysfunction Related to Brain Injury : Evidence for Catecholamine-Mediated Myocardial Damage Circulation, October 15, 1995; 92(8): 2183 - 2189. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |